Search Results - Allison Beck
- Showing 1 - 2 results of 2
-
1
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure by Lilin Lai, Kevin Ault, Nadine Rouphael, Allison Beck, Briyana Domjahn, Yongxian Xu, Evan J. Anderson, Andrew Cheng, Aya Nakamura, Rebecca J. Hoagland, Colleen Kelley, Srilatha Edupuganti, Karen Mask, Mirjana Nesin, Elizabeth R. Unger, Gitika Panicker, Hagit David, Mark J. Mulligan
Published in Vaccines (2020-06-01)Get full text
Article -
2
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials by Myra Happe, Amelia R. Hofstetter, Jing Wang, Galina V. Yamshchikov, LaSonji A. Holman, Laura Novik, Larisa Strom, Francis Kiweewa, Salim Wakabi, Monica Millard, Colleen F. Kelley, Sarah Kabbani, Srilatha Edupuganti, Allison Beck, Florence Kaltovich, Tamar Murray, Susanna Tsukerman, Derick Carr, Carl Ashman, Daphne A. Stanley, Aurélie Ploquin, Robert T. Bailer, Richard Schwartz, Fatim Cham, Allan Tindikahwa, Zonghui Hu, Ingelise J. Gordon, Nadine Rouphael, Katherine V. Houser, Emily E. Coates, Barney S. Graham, Richard A. Koup, John R. Mascola, Nancy J. Sullivan, Merlin L. Robb, Julie A. Ake, Kirsten E. Lyke, Mark J. Mulligan, Julie E. Ledgerwood, Hannah Kibuuka, the VRC 208 and RV 422 study team
Published in npj Vaccines (2024-03-01)Get full text
Article
